EXACTAMIX Compounders 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Baxter 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-07-17
  • 사례 출판 날짜
    2014-07-17
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: baxter exactamix compounders medical device manufacturer, baxter, has issued a field safety notice concerning exactamix compounders with model numbers 2400-dy and 1200-dy. the exactamix compounder uses a universal ingredient (ui) to flush the common fluid pathway at the end of compounding activities. if the ui in an active configuration is changed using the configuration editor rather than following the normally prescribed and supported methods as outlined in the operator manual, a flush of the outlet pump tube will not be initiated by the software. as a result, the original ui may remain in the tube and could be delivered into the next bag. this could lead to an over delivery of the first ui, an under delivery of the subsequent ui, or a delivery of an unintended ui. drug incompatibilities or drug-drug interactions are not reasonably expected with this issue because the uis are normally sterile water for injection, dextrose 50% and dextrose 70%. the worst case scenario would be an unintended rapid infusion of 13.7g of dextrose into a diabetic patient causing hyperglycemia, which may require medical intervention. the manufacturer is updating the em2400 and emi200 operator manuals to provide further clarification – “the configuration editor is to be used only to create and manage non-active configurations. all changes to the ui of an active configuration must be made through the “change ui” functionality described.” according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 17 jul 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Baxter EXACTAMIX Compounders
  • Manufacturer

Manufacturer